Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Werfen Group to acquire Inova Diagnostics
The transaction is expected to close in the first quarter of 2008, subject to required government approvals. Financial terms have not been disclosed. Sr Jose Martin, spokesperson for
The transaction is expected to close in the first quarter of 2008, subject to required government approvals. Financial terms have not been disclosed. Sr Jose Martin, spokesperson for
Patients in the study were followed for six months. The company said that technical success was achieved in 98% of the patients. The side effects of fibroids such
Sugammadex is specifically designed to rapidly reverse the effects of certain muscle relaxants, rocuronium bromide (marketed in the US as Zemuron and in Japan as Eslax), as well
Teva’s Pravastatin sodium tablets, 80mg are the AB-rated generic equivalent of Bristol-Myers Squibb’s Pravachol 80mg tablets, and are indicated for treatment of certain hyperlipidemias and the primary prevention
Under a global collaboration, Bayer HealthCare Pharmaceuticals will support the launch of Recothrom in the US for three years. The FDA approval triggers a $40 million milestone payment
The company plans to expand the clinical trial of systemic ADH-1 in combination with isolated limb infusion melphalan for the treatment of melanoma by up to 25 additional
The first Phase I clinical study will be performed in Denmark, with the first subject expected to be recruited in the study soon. The trial is a double-blind
The FDA has agreed that Novagali may proceed with Phase I clinical trials in the US in patients with diabetic macular edema (DME) aiming to evaluate the safety
The company expects a second close in second quarter of 2008, which may involve an additional new investor. The proceeds of the financing are primarily being used to
The study demonstrated that the higher, antimicrobial dose does not provide a greater clinical benefit than the anti-inflammatory dose of 40mg, controlled release. However, the higher dose was